Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

DARU Journal of Pharmaceutical Sciences | ResearchHub - ResearchHub

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

ResearchGate

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Journal graph

DARU Journal of Pharmaceutical Sciences

Springer Science and Business Media LLC · ISSN 2008-2231

6

Verified works

0

Citations

—

Access

Researchers publishing here

11 linked researchers

Natsuko Kameyama Ayana Ide Hideki Maeda Madhusudan Purohit Shobha Singh Anurag Biswas Pallvi Kumari Kaunava Roy Chowdhury Preeti Kanawjia Seyed Hamdollah Mosavat Mohammad Hashem Hashempur

Research in this journal

BAY-876 restores lenvatinib sensitivity in resistant hepatocellular carcinoma cells by disrupting the GLUT1–SLC7A11–NADPH redox axis2026 · Ranran Xue · 0 citations

Emerging nanostructured platforms for improved oral delivery of antidiabetic agents: overcoming physiological barriers and enhancing therapeutic efficacy2026 · Shweta Yadav, Prashant Singh, Madhusudan Purohit · 0 citations

Pharmacomicrobiomics-driven targeted drug delivery for precision microbiome modulation2026 · Anurag Biswas, Bijoy Ghosh, Pallvi Kumari · 0 citations

Effects of rosehip (Rosa canina) supplementation on orthostatic intolerance symptoms in patients with type 2 diabetes: a randomized double-blind placebo-controlled clinical trial2026 · Seyed Yaser Ghelmani, Seyede Hamide Rajaie, Roghayeh Zare · 0 citations

Sodium oxybate for excessive daytime sleepiness in narcolepsy: a systematic review and meta-analysis of randomized placebo-controlled trials

2026 · Preeti Kanawjia, Surendra Kumar Kanaujia, Renu Kumari · 0 citations

Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination2026 · Natsuko Kameyama, Ayana Ide, Hideki Maeda · 0 citations